Carina Lundberg-Vingsbo
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The COMBINE pneumonia model: a multicenter study to standardize a mouse pneumonia model with Pseudomonas aeruginosa and Klebsiella pneumoniae for antibiotic development.
Journal: Microbiology spectrum
Published: January 14, 2026
Model-based translation of the PKPD-relationship for linezolid and vancomycin on methicillin-resistant Staphylococcus aureus: from in vitro time-kill experiments to a mouse pneumonia model.
Journal: The Journal of antimicrobial chemotherapy
Published: February 08, 2025
Model-informed drug development for antimicrobials: translational pharmacokinetic-pharmacodynamic modelling of apramycin to facilitate prediction of efficacious dose in complicated urinary tract infections.
Journal: The Journal of antimicrobial chemotherapy
Published: May 13, 2024
Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 05, 2024
Apramycin efficacy against carbapenem- and aminoglycoside-resistant Escherichia coli and Klebsiella pneumoniae in murine bloodstream infection models.
Journal: International journal of antimicrobial agents
Published: June 02, 2023
Cryptic susceptibility to penicillin/β-lactamase inhibitor combinations in emerging multidrug-resistant, hospital-adapted Staphylococcus epidermidis lineages.
Journal: Nature communications
Published: April 04, 2023
Translational in vitro and in vivo PKPD modelling for apramycin against Gram-negative lung pathogens to facilitate prediction of human efficacious dose in pneumonia.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: December 18, 2021
Antibacterial activity of apramycin at acidic pH warrants wide therapeutic window in the treatment of complicated urinary tract infections and acute pyelonephritis.
Journal: EBioMedicine
Published: June 23, 2021
ENABLE: an engine for European antibacterial drug discovery and development.
Journal: Nature reviews. Drug discovery
Published: May 05, 2021
Model-Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin.
Journal: Clinical pharmacology and therapeutics
Published: September 01, 2020
Genomic identification of cryptic susceptibility to penicillins and β-lactamase inhibitors in methicillin-resistant Staphylococcus aureus.
Journal: Nature microbiology
Published: February 21, 2019
In Vitro and In Vivo Characterization of NOSO-502, a Novel Inhibitor of Bacterial Translation.
Journal: Antimicrobial agents and chemotherapy
Published: May 23, 2018
Last Updated: 09/26/2026